Ledyard National Bank’s Charles River Laboratories CRL Stock Holding History

Ledyard National Bank’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-48	Closed	-$5K	–	342
2018 Q4	$5K	Hold	48	–	–	﹤0.01%	666
2018 Q3	$6K	Hold	48	–	–	﹤0.01%	640
2018 Q2	$5K	Hold	48	–	–	﹤0.01%	659
2018 Q1	$5K	Hold	48	–	–	﹤0.01%	699
2017 Q4	$5K	Hold	48	–	–	﹤0.01%	726
2017 Q3	$5K	Hold	48	–	–	﹤0.01%	715
2017 Q2	$5K	Sell	48 -144	-75%	-$13.3K	﹤0.01%	669
2017 Q1	$17K	Buy	192 +100	+109%	+$8.49K	﹤0.01%	541
2016 Q4	$7K	Hold	92	–	–	﹤0.01%	527
2016 Q3	$8K	Hold	92	–	–	﹤0.01%	516
2016 Q2	$8K	Hold	92	–	–	﹤0.01%	490
2016 Q1	$7K	Hold	92	–	–	﹤0.01%	562
2015 Q4	$7K	Hold	92	–	–	﹤0.01%	558
2015 Q3	$6K	Hold	92	–	–	﹤0.01%	565
2015 Q2	$6K	Hold	92	–	–	﹤0.01%	578
2015 Q1	$7K	Hold	92	–	–	﹤0.01%	536
2014 Q4	$6K	Hold	92	–	–	﹤0.01%	579
2014 Q3	$5K	Hold	92	–	–	﹤0.01%	578
2014 Q2	$5K	Hold	92	–	–	﹤0.01%	585
2014 Q1	$6K	Hold	92	–	–	﹤0.01%	529
2013 Q4	$5K	Buy	+92	New	+$4.62K	﹤0.01%	574

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Ledyard National Bank's CRL Position: Q1 2019 in Review

Ledyard National Bank sold out of Charles River Laboratories (CRL) in Q1 2019, closing a stake of 48 shares — an estimated $5K sold.

Ledyard National Bank first reported a position in CRL in Q4 2013 and held it in 21 quarters. The position peaked at $17K in Q1 2017. 409 funds tracked by Wall St. Rank hold CRL as of Q1 2019.

Ledyard National Bank reported no remaining Charles River Laboratories position as of Q1 2019 after selling out during the quarter.
Ledyard National Bank sold 48 Charles River Laboratories shares in Q1 2019, an estimated $5K.
Ledyard National Bank first reported a position in Charles River Laboratories in Q4 2013 and held it in 21 quarters.
Ledyard National Bank's Charles River Laboratories position peaked at $17K in Q1 2017.
409 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2019.

Based on Ledyard National Bank's 13F filing for Q1 2019, filed 12 Apr 2019.